Literature DB >> 24649174

Histological profile and age at diagnosis of breast and ovarian tumors: A register-based study in Espirito Santo, Brazil.

Eldamária DE Vargas Wolfgramm1, Camila Fátima Biancardi Gavioli1, Mayara Lemos Entringer1, Lyvia Neves Rebello Alves1, Elaine Stur1, Allan Kardec DE Castro Neto2, Luciene Lage DA Motta3, Fausto Edmundo Lima Pereira1, Iuri Drumond Louro1.   

Abstract

Breast and ovarian cancers are important public health problems in Brazil. However, in various locations in the Brazilian territory these types of cancer remain poorly characterized. Therefore, this study aimed to compare data collected from the Pathology Services of two Oncology Reference Hospitals in Espirito Santo state (Brazil) with the data in previous Brazilian studies. Histological type frequency and age at diagnosis of breast and ovarian tumors between 2001-2004 and 2009-2010 were analyzed. Tumor size, histological grade, lymph node status, hormone receptor status [estrogen (ER) and progesterone receptors (PR)] as well as HER2 and Ki-67 marker status were obtained for the cases of infiltrating ductal carcinomas of the breast during the period 2009-2010. Categorical variables were described by their absolute and/or relative frequencies, while quantitative variables were expressed as the mean ± standard deviation and median, using 95% confidence intervals. Chi-square tests were performed to examine whether or not the studied variables differed by age at the time of diagnosis. Malignant breast tumors (1,758) and 119 malignant ovarian tumors were examined. Mean ages for malignant breast and ovarian tumors were 53.59 and 52.98 years, respectively. An increased tumor frequency in the age group of ≤35 years was observed for other malignant tumors of the breast during the period of 2009-2010, compared to 2001-2004. When considering only infiltrating ductal carcinomas with immunohistochemistry records available, there were 82.1% (133 cases) of ER+/PR+ tumors, 1.9% (3 cases) of ER-/PR-/HER2 3+ and 16.04% (26 cases) of ER-/PR-/HER2- tumors. The findings of this study demonstrated detailed information concerning breast and ovarian tumor behavior in the Espirito Santo state (Brazil), allowing for a precise comparison with other populations (Brazilian or international), which may be helpful in the planning of prevention and treatment strategies.

Entities:  

Keywords:  Brazil; breast and ovarian tumors; epidemiology; histological data

Year:  2012        PMID: 24649174      PMCID: PMC3956274          DOI: 10.3892/mco.2012.38

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  10 in total

1.  Incidence trend for breast cancer among young women in Goiânia, Brazil.

Authors:  Ruffo Freitas; Nilceana Maya Aires Freitas; Maria Paula Curado; Edesio Martins; Carleane Maciel Bandeira Silva; Rosemar Macedo Sousa Rahal; Geraldo Silva Queiroz
Journal:  Sao Paulo Med J       Date:  2010       Impact factor: 1.044

2.  Geographical variations in TP53 mutational spectrum in ovarian carcinomas.

Authors:  A Dansonka-Mieszkowska; A H Ludwig; E Kraszewska; J Kupryjańczyk
Journal:  Ann Hum Genet       Date:  2006-09       Impact factor: 1.670

Review 3.  TP53 and ovarian cancer.

Authors:  Monique Schuijer; Els M J J Berns
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

4.  [Age as an independent prognostic factor in breast cancer].

Authors:  Willian Simões Clagnan; Jurandyr Moreira de Andrade; Hélio Humberto Angotti Carrara; Daniel Guimarães Tiezzi; Francisco José Candido dos Reis; Heitor Ricardo Cosiski Marana; Renato Antonio Abrão
Journal:  Rev Bras Ginecol Obstet       Date:  2008-02

Review 5.  Accuracy of CA 125 in the diagnosis of ovarian tumors: a quantitative systematic review.

Authors:  Lidia Rosi Medeiros; Daniela Dornelles Rosa; Maria Inês da Rosa; Mary Clarisse Bozzetti
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2008-11-07       Impact factor: 2.435

6.  [Five-year survival and prognostic factors in a cohort of breast cancer patients treated in Juiz de Fora, Minas Gerais State, Brazil].

Authors:  Maximiliano Ribeiro Guerra; Gulnar Azevedo E Silva Mendonça; Maria Teresa Bustamante-Teixeira; Jane Rocha Duarte Cintra; Lilian Marzullo de Carvalho; Lydia Maria Pereira Vaz de Magalhães
Journal:  Cad Saude Publica       Date:  2009-11       Impact factor: 1.632

7.  Ultrasonography in the diagnosis of tumors of the ovary.

Authors:  M DeLand; A Fried; J R van Nagell; E S Donaldson
Journal:  Surg Gynecol Obstet       Date:  1979-03

8.  [Five-year survival and prognostic factors in women with breast cancer in Santa Catarina State, Brazil].

Authors:  Ione Jayce Ceola Schneider; Eleonora d'Orsi
Journal:  Cad Saude Publica       Date:  2009-06       Impact factor: 1.632

9.  Clinical characterization and risk profile of individuals seeking genetic counseling for hereditary breast cancer in Brazil.

Authors:  Edenir Inez Palmero; Patricia Ashton-Prolla; José Cláudio C da Rocha; Fernando Regla Vargas; Luciane Kalakun; Melissa Brauner Blom; Sérgio J Azevedo; Maira Caleffi; Roberto Giugliani; Lavinia Schüler-Faccini
Journal:  J Genet Couns       Date:  2007-02-23       Impact factor: 2.717

10.  Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.

Authors:  Patricia Ashton-Prolla; Juliana Giacomazzi; Aishameriane V Schmidt; Fernanda L Roth; Edenir I Palmero; Luciane Kalakun; Ernestina S Aguiar; Susana M Moreira; Erica Batassini; Vanessa Belo-Reyes; Lavinia Schuler-Faccini; Roberto Giugliani; Maira Caleffi; Suzi Alves Camey
Journal:  BMC Cancer       Date:  2009-08-14       Impact factor: 4.430

  10 in total
  1 in total

1.  Is There any Concordance between of IHC with FISH in HER2-Positive Breast Cancer Patients?

Authors:  Mehrdad Payandeh; Masoud Sadeghi; Edris Sadeghi; Alireza Janbakhsh
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.